United States: FTC Alleges Misuse Of Orange Book Listings: Puts10 Pharma Companies On Notice - Oblon, McClelland, Maier & Neustadt, L.L.P

Mondaq

15 Nov 2023 0 shares 1 views

United States: FTC Alleges Misuse Of Orange Book Listings: Puts10 Pharma Companies On Notice - Oblon, McClelland, Maier & Neustadt, L.L.P

Mondaq

Published 15 Nov 2023

On Tuesday, the FTC announced that it is cracking down on companies it asserts is improperly or inaccurately placing drugs on the list of FDA-approved products...

Full Article

United States: Fanning The Flames: FTC Takes Action Against Alleged Improper Orange Book Patent Listings - Buchanan Ingersoll & Rooney PC

On November 7, 2023, the Federal Trade Commission (FTC) took unprecedented action by issuing notice letters to ten pharmaceutical..

Mondaq 21 Nov 2023

United States: Federal Trade Commission Issues Notice Letters Regarding Allegedly Improper Orange Book Listings - Duane Morris LLP

On November 7, 2023, the Federal Trade Commission ("FTC") announced that it had issued notice letters to 10 life sciences companies..

Mondaq 13 Nov 2023

United States: FTC Alleges Misuse Of Orange Book Listings: Puts10 Pharma Companies On Notice - Oblon, McClelland, Maier & Neustadt, L.L.P

United States: FTC Alleges Misuse Of Orange Book Listings: Puts10 Pharma Companies On Notice - Oblon, McClelland, Maier & Neustadt, L.L.P

You might like

Related news coverage

United States: Fanning The Flames: FTC Takes Action Against Alleged Improper Orange Book Patent Listings - Buchanan Ingersoll & Rooney PC

United States: Federal Trade Commission Issues Notice Letters Regarding Allegedly Improper Orange Book Listings - Duane Morris LLP

Advertisement